\-\ Texto\\:\\ \ \(0\)\
\-\ mri\\ pelvis\\ with\\ and\\ without\\ gadolinium\\.\\ \\ sequences\\ include\\ axial\\ and\\ coronal\\ t1\\ pre\\ without\\ fat\\ saturation\\,\\ axial\\ t2\\ fat\\ saturation\\,\\ coronal\\ stir\\,\\ and\\ axial\\ and\\ coronal\\ t1\\ post\\ gadolinium\ \(0\)\
\-\ apart\\ from\\ a\\ minimally\\ elevated\\ erythrocyte\\ sedimentation\\ rate\\,\\ the\\ patients\\ laboratory\\ profile\\ is\\ normal\\;\\ there\\ is\\ hla\\-b27\\ abnormality\\.\\ \\ no\\ clinical\\ or\\ laboratory\\ finding\\ of\\ infection\\ is\\ present\\.\\ \ \(0\)\
\-\ currently\\,\\ the\\ patient\\ is\\ managed\\ with\\ nsaids\\.\ \(0\)\
\-\ 1\\)\\ \\ sclerosis\\ and\\ irregularity\\ of\\ the\\ sacroiliac\\ joints\\ with\\ only\\ trace\\ marrow\\ edema\\ and\\ no\\ significant\\ enhancement\\ to\\ indicate\\ an\\ acute\\ erosive\\ process\\.\ \(0\)\
\-\ sacroiliitis\\ without\\ identified\\ etiology\\.\ \(0\)\
\-\ sacroiliitis\\ etiologies\\:\ \(0\)\
\-\ idiopathic\ \(111\)\
\-\ infection\ \(713\)\
\-\ ankylosing\\ spondylitis\ \(23\)\
\-\ ibd\ \(0\)\
\-\ psoriasis\ \(16\)\
\-\ rheumatoid\\ arthritis\ \(67\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ 21\\ yo\\ enlisted\\ sailor\\ with\\ 2\\ year\\ history\\ of\\ bilateral\\ hip\\ and\\ lower\\ back\\ pain\\ with\\ 2\\-3\\ hours\\ morning\\ stiffness\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sacroiliitis\\:\\ 0\\.09905995415127444\ \(0\)\
\-\ coronal\\:\\ 0\\.07848580261629523\ \(0\)\
\-\ saturation\\:\\ 0\\.07399012926541525\ \(0\)\
\-\ enlisted\\:\\ 0\\.059723317966224654\ \(0\)\
\-\ gadolinium\\:\\ 0\\.05960800719365797\ \(0\)\
\-\ axial\\:\\ 0\\.053796870795614814\ \(0\)\
\-\ sailor\\:\\ 0\\.052985886114208805\ \(0\)\
\-\ hla\\-b27\\:\\ 0\\.04952997707563722\ \(0\)\
\-\ erythrocyte\\:\\ 0\\.0465486159866066\ \(0\)\
\-\ laboratory\\:\\ 0\\.0463101725860892\ \(0\)\
\-\ apart\\:\\ 0\\.04596006666547765\ \(0\)\
\-\ psoriasis\\:\\ 0\\.04490785457988447\ \(0\)\
\-\ ibd\\:\\ 0\\.044433306630343505\ \(0\)\
\-\ without\\:\\ 0\\.044382643375547655\ \(0\)\
\-\ sedimentation\\:\\ 0\\.04209173507800134\ \(0\)\
\-\ sacroiliac\\:\\ 0\\.04209173507800134\ \(0\)\
\-\ pre\\:\\ 0\\.04145194554131288\ \(0\)\
\-\ trace\\:\\ 0\\.04145194554131288\ \(0\)\
\-\ stir\\:\\ 0\\.04086339622018394\ \(0\)\
\-\ profile\\:\\ 0\\.04086339622018394\ \(0\)\
\-\ t1\\:\\ 0\\.03983081670918005\ \(0\)\
\-\ stiffness\\:\\ 0\\.038677723253507976\ \(0\)\
\-\ fat\\:\\ 0\\.03821929886590637\ \(0\)\
\-\ ankylosing\\:\\ 0\\.03807303135470671\ \(0\)\
\-\ spondylitis\\:\\ 0\\.037514311450457284\ \(0\)\
\-\ erosive\\:\\ 0\\.03733712357119948\ \(0\)\
\-\ infection\\:\\ 0\\.03652965550107069\ \(0\)\
\-\ indicate\\:\\ 0\\.03562666551775277\ \(0\)\
\-\ etiologies\\:\\ 0\\.03483809544162337\ \(0\)\
\-\ morning\\:\\ 0\\.034355762482168865\ \(0\)\
\-\ nsaids\\:\\ 0\\.03390313091599656\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.03390313091599656\ \(0\)\
\-\ managed\\:\\ 0\\.03379419646169406\ \(0\)\
\-\ irregularity\\:\\ 0\\.03358105280821426\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.03297636090941299\ \(0\)\
\-\ minimally\\:\\ 0\\.03269169537867262\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.029679374491580653\ \(0\)\
\-\ joints\\:\\ 0\\.0287517915112358\ \(0\)\
\-\ idiopathic\\:\\ 0\\.02864365807454686\ \(0\)\
\-\ 21\\:\\ 0\\.02843204804109066\ \(0\)\
\-\ marrow\\:\\ 0\\.027641710431016105\ \(0\)\
\-\ arthritis\\:\\ 0\\.026843620956198414\ \(0\)\
\-\ etiology\\:\\ 0\\.02659574553456377\ \(0\)\
\-\ sequences\\:\\ 0\\.026238929057397147\ \(0\)\
\-\ hip\\:\\ 0\\.025028473324348956\ \(0\)\
\-\ currently\\:\\ 0\\.024898329375088655\ \(0\)\
\-\ hours\\:\\ 0\\.02470733315153527\ \(0\)\
\-\ rate\\:\\ 0\\.024490599194675316\ \(0\)\
\-\ process\\:\\ 0\\.02419165797672584\ \(0\)\
\-\ abnormality\\:\\ 0\\.023180573116401117\ \(0\)\
\-\ pelvis\\:\\ 0\\.022831554460232564\ \(0\)\
\-\ sclerosis\\:\\ 0\\.022568494363429007\ \(0\)\
\-\ identified\\:\\ 0\\.022451963538134716\ \(0\)\
\-\ elevated\\:\\ 0\\.021318502657051933\ \(0\)\
\-\ back\\:\\ 0\\.02072842893637851\ \(0\)\
\-\ finding\\:\\ 0\\.020250452242930008\ \(0\)\
\-\ post\\:\\ 0\\.019785551713766864\ \(0\)\
\-\ clinical\\:\\ 0\\.019333160294602973\ \(0\)\
\-\ yo\\:\\ 0\\.01890699649487325\ \(0\)\
\-\ only\\:\\ 0\\.018892732782977466\ \(0\)\
\-\ t2\\:\\ 0\\.017783740946693764\ \(0\)\
\-\ edema\\:\\ 0\\.017771496245818315\ \(0\)\
\-\ include\\:\\ 0\\.017626128588457992\ \(0\)\
\-\ significant\\:\\ 0\\.01689593493422223\ \(0\)\
\-\ enhancement\\:\\ 0\\.01684182916266938\ \(0\)\
\-\ is\\:\\ 0\\.01653796407013899\ \(0\)\
\-\ patients\\:\\ 0\\.016261577936514896\ \(0\)\
\-\ acute\\:\\ 0\\.015513818596371288\ \(0\)\
\-\ bilateral\\:\\ 0\\.01524865977437091\ \(0\)\
\-\ 1\\:\\ 0\\.014950929176174315\ \(0\)\
\-\ \\;\\:\\ 0\\.014892802856269071\ \(0\)\
\-\ mri\\:\\ 0\\.014435851874372204\ \(0\)\
\-\ present\\:\\ 0\\.014191240837732946\ \(0\)\
\-\ lower\\:\\ 0\\.01413133874532252\ \(0\)\
\-\ 2\\:\\ 0\\.013530180121401074\ \(0\)\
\-\ no\\:\\ 0\\.0126535904515265\ \(0\)\
\-\ \\,\\:\\ 0\\.009952575938135566\ \(0\)\
\-\ normal\\:\\ 0\\.009850091577934567\ \(0\)\
\-\ there\\:\\ 0\\.009350849679889623\ \(0\)\
\-\ from\\:\\ 0\\.009312027302604503\ \(0\)\
\-\ and\\:\\ 0\\.009265169412687714\ \(0\)\
\-\ an\\:\\ 0\\.00868871223738772\ \(0\)\
\-\ history\\:\\ 0\\.008678048071375613\ \(0\)\
\-\ \\:\\:\\ 0\\.008310844235225478\ \(0\)\
\-\ pain\\:\\ 0\\.007673589467137755\ \(0\)\
\-\ or\\:\\ 0\\.007364137860027261\ \(0\)\
\-\ year\\:\\ 0\\.007030185803477314\ \(0\)\
\-\ patient\\:\\ 0\\.006298470080267559\ \(0\)\
\-\ \\)\\:\\ 0\\.005246600677303714\ \(0\)\
\-\ with\\:\\ 0\\.004301624120951829\ \(0\)\
\-\ to\\:\\ 0\\.00314020667972784\ \(0\)\
\-\ the\\:\\ 0\\.003049616574344687\ \(0\)\
\-\ a\\:\\ 0\\.0029161750133720682\ \(0\)\
\-\ of\\:\\ 0\\.0025699367823085683\ \(0\)\
\-\ \\.\\:\\ 0\\.00182718200501047\ \(0\)\
